Publications

Obvia’s Spirit of Discovery

Obvia = latin: “she who steps into the way and confronts danger directly.”

Obvia’s Groundbreaking Science is built on Two Decades of rigorous, Peer-reviewed Proof-of-Concept Research demonstrating a clear Link between PrC-210’s Mechanism of Action and its Ability to address the Root Cause of Disease.

Obvia Pharmaceuticals Journal Articles Relating to PrC-210

Obvia 3/22/25 Obvia 3/22/25

Synthesis and Growth Regulatory Activity of a Prototype Member of a New Family of Aminothiol Radioprotectors

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

ROS-Scavenger and Radioprotective Efficacy of the New PrC-210 Aminothiol

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Radioprotective Efficacy and Toxicity of a New Family of Aminothiol Analogs.

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Radioprotective Effect of Aminothiol PrC-210 on Irradiated Inner Ear of Guinea Pig

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Impact of the PrC-210 Radioprotector Molecule on Cancer Deaths in p53-Deficient –/– Mice

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant Suppression of CT Radiation-Induced DNA Damage in Normal Human Cells by the PrC-210 Radioprotector

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Reduction of X-ray-induced DNA damage in normal human cells treated with the PrC-210 radioprotector

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant Reduction of Murine Renal Ischemia-Reperfusion Cell Death Using the Immediate-Acting PrC-210 Reactive Oxygen Species Scavenger

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant reduction of ischemia‐reperfusion cell death in mouse myocardial infarcts using the immediate‐acting PrC‐210 ROS‐scavenger

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Determination of plasma levels of the active thiol form of the direct-acting PrC-210 ROS-scavenger using a fluorescence-based assay

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant Reduction of Total-Body Irradiation-Induced Death in Mice Treated with PrC-210 24 Hours Postirradiation

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

PrC-210 Protects against Radiation-Induced Hematopoietic and Intestinal Injury in Mice and Reduces Oxidative Stress

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant Reduction of Radiation-Induced Death in Mice Treated with PrC-210 and G-CSF after Irradiation

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Assay of PrC-210 Thiol in Plasma and Tissues by Liquid Chromatography Coupled with Tandem Mass Spectrometry

PrC-210 Publications

Obvia 3/22/25 Obvia 3/22/25

Significant Suppression of Multiple Sclerosis in the Mouse EAE Model Using the PrC-210 Aminothiol

PrC-210 Publications

Obvia 3/11/19 Obvia 3/11/19

Significantly Improved Cold Preservation of Rat Hind Limb Vascularized Composite Allografts Using the New PrC-210 Free Radical Scavenger

PrC-210 Publications

Publications

Obvia’s Spirit of Discovery

Obvia’s Groundbreaking Science is built on Two Decades of rigorous, Peer-reviewed Proof-of-Concept Research demonstrating a clear Link between PrC-210’s Mechanism of Action and its Ability to address the Root Cause of Disease.

Obvia Pharmaceuticals Journal Articles Relating to PrC-210

Synthesis and Growth Regulatory Activity of a Prototype Member of a New Family of Aminothiol Radioprotectors

A New Orally Active, Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses

ROS-Scavenger and Radioprotective Efficacy of the New PrC-210 Aminothiol

Radioprotective Efficacy and Toxicity of a New Family of Aminothiol Analogs.

Radioprotective Effect of Aminothiol PrC-210 on Irradiated Inner Ear of Guinea Pig

Impact of the PrC-210 Radioprotector Molecule on Cancer Deaths in p53-Deficient –/– Mice

Significant Suppression of CT Radiation-Induced DNA Damage in Normal Human Cells by the PrC-210 Radioprotector

Reduction of X-ray-induced DNA damage in normal human cells treated with the PrC-210 radioprotector

Significant Reduction of Murine Renal Ischemia-Reperfusion Cell Death Using the Immediate-Acting PrC-210 Reactive Oxygen Species Scavenger

Significant reduction of ischemia‐reperfusion cell death in mouse myocardial infarcts using the immediate‐acting PrC‐210 ROS‐scavenger

Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats

Determination of plasma levels of the active thiol form of the direct-acting PrC-210 ROS-scavenger using a fluorescence-based assay

Significant Reduction of Total-Body Irradiation-Induced Death in Mice Treated with PrC-210 24 Hours Postirradiation

PrC-210 Protects against Radiation-Induced Hematopoietic and Intestinal Injury in Mice and Reduces Oxidative Stress

Significant Reduction of Radiation-Induced Death in Mice Treated with PrC-210 and G-CSF after Irradiation

Assay of PrC-210 Thiol in Plasma and Tissues by Liquid Chromatography Coupled with Tandem Mass Spectrometry

Significant Suppression of Multiple Sclerosis in the Mouse EAE Model Using the PrC-210 Aminothiol

Significantly Improved Cold Preservation of Rat Hind Limb Vascularized Composite Allografts Using the New PrC-210 Free Radical Scavenger

Obvia Pharmaceuticals

Bay Area

Madison

Contact